ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Vascular surgery · J Vasc Surg · 2026-08-03

Meta-analysis of 17 studies (5290 patients, 5492 limbs) with chronic limb-threatening ischaemia: GLASS III vs I was associated with higher mortality (HR 1.28), MALE (HR 1.36) and patency loss (HR 2.23); in GLASS III, endovascular vs bypass had higher MALE (HR 1.88).

Meta-analysisn = 5,290
Melo et al. A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system
Vascular surgery · Ann Vasc Surg · 2026-07-14

Meta-analysis of 10 observational studies (50,242 patients) with CLTI undergoing revascularisation: diabetes was associated with higher mortality (HR 1.23) and major amputation (HR 1.43); amputation risk was significant only at ≥3 years, with substantial heterogeneity.

Meta-analysisn = 50,242
Estevam et al. Impact of Diabetes on Outcomes after Lower Limb Revascularization in Patients with Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis
Vascular surgery · J Vasc Surg · 2026-05-22

Systematic review of 10 observational studies (5794 participants): elevated Lp(a) was associated with PAD prevalence (pooled OR 1.81). After lower-extremity revascularisation, in only 2 cohorts, it was linked to major adverse limb events (OR 5.09) and major amputation (OR 2.62).

Meta-analysisn = 5,794
Mwipatayi et al. A systematic review and meta-analysis of elevated lipoprotein(a) and adverse limb outcomes in peripheral artery disease after revascularization
Vascular surgery · Ann Vasc Surg · 2026-05-12

Phase 3 trial of REX-001 bone marrow cell therapy in diabetic patients with no-option chronic limb-threatening ischaemia, stopped early for lack of efficacy at interim analysis: ulcer healing or Rutherford improvement in 28.6% vs 27.3% with placebo (32 completed).

RCTn = 32
Peeters et al. The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes
Vascular surgery · Ann Vasc Surg · 2026-03-27

Systematic review of 42 studies (2,237 patients) of cryopreserved allografts for infrainguinal bypass: pooled 1-year primary patency 51.1%, survival 85.0%, major amputation 20.2%; arterial grafts had higher patency than venous (67.6% vs 39.6%). Very low certainty.

Meta-analysisn = 2,237
Buongiovanni et al. Do Arterial Allografts Outperform Venous in Cryopreserved Bypass for Limb Salvage? A Systematic Review and Meta-Analysis of Infrainguinal Revascularization Outcomes
Vascular surgery · Eur J Vasc Endovasc Surg · 2026-02-02

Secondary analysis of 785 patients with chronic limb-threatening ischaemia in BEST-CLI: early improvement in WIfI ischaemia grade after revascularisation (80.1% of patients) was associated with lower 1-year major amputation risk (adjusted HR 0.27).

Secondary analysisn = 785
Brooke et al. Editor's Choice - Early Improvement in Wound, Ischaemia, and foot Infection (WIfI) Ischaemia Grade Lowers Risk of Major Amputation following Revascularisation for Chronic Limb Threatening Ischaemia
Vascular surgery · J Vasc Surg · 2026-01-21

Systematic review of 25 studies with Bayesian network meta-analysis in chronic limb-threatening ischaemia: direct and collateral-guided indirect infrapopliteal revascularisation had comparable wound healing, amputation-free survival and limb salvage, both superior to indirect.

Meta-analysisn = 25 studies
Guo et al. Bayesian network meta-analysis and systematic review of endovascular revascularization strategies for infrapopliteal arteries in chronic limb-threatening ischemia
Vascular surgery · Eur J Vasc Endovasc Surg · 2025-12-24

Secondary analysis of BEST-CLI patients with CLTI, by treatment received: over 90% had improved ABI or toe pressure 30 days after revascularisation; with usable great saphenous vein, median toe pressure rose more after bypass than endovascular therapy (40 vs 29 mmHg).

Secondary analysis
Venermo et al. Baseline Haemodynamic Measurements and Immediate Change in Parameters after Revascularisation: Ankle Pressure, Ankle Brachial Index, Toe Pressure, and Toe Brachial Index Analysis of the BEST-CLI Participants
Vascular surgery · Eur J Vasc Endovasc Surg · 2025-12-01

Systematic review of 140 studies of major lower limb amputation for PAD or diabetes: 30-day mortality 8.7%; time-to-event analysis of 19 studies (59,999 patients) estimated mortality of 28.9% at 1 year and 63.0% at 5 years, median survival 3.1 years.

Meta-analysisn = 140 studies
Leatherby et al. Editor's Choice - Systematic Review, Meta-analysis, and Time to Event Analysis of Contemporary Mortality after Major Lower Limb Amputation for Peripheral Arterial Disease or Diabetes Mellitus
Vascular surgery · Eur J Vasc Endovasc Surg · 2025-10-24

Secondary analysis of the BEST-CLI trial (1830 patients with chronic limb threatening ischaemia): higher modified GLASS stage was associated with worse limb outcomes after endovascular therapy but not open bypass; bypass had fewer re-interventions and amputations in stages 2-3.

Secondary analysisn = 1,830
McGinigle et al. Editor's Choice - Association Between Anatomical Patterns of Arterial Occlusive Disease and Endovascular Outcomes in the BEST-CLI Trial Supports the Use of the Global Limb Anatomic Staging System

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.